Startup | November 18, 2021
Illumina and Sequoia Capital China selects startups for Genomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
The investment will increase SpeeDx internal capacity to scale up manufacturing
Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
Subscribe To Our Newsletter & Stay Updated
